While it has been studied over one to two years in clinical trials, there is limited data beyond that time frame, especially regarding: Long-term metabolic effects Nutrient deficiencies due to reduced food intake Potential changes to gut microbiota Dependency on the drug to maintain weight loss Potential changes to gut microbiota Some clinicians have voiced concern that stopping Ozempic can result in rapid weight regain and the return of previous metabolic issues
Boxed warning for Contrave : Contrave has a boxed warning due to the increased risk of suicidal thoughts and behaviors
higher for those who stayed on treatment HbA1c fell by 1.91 percentage points from a mean baseline of 8.2% 73.5% of participants reached HbA1c 6.5%, a normal blood sugar threshold Compared to 15.9% with placebo Diabetes patients typically lose less weight on GLP-1 drugs than non-diabetic patients this pattern holds with CagriSema
Can I take Flecainide and Wegovy together
Antioxidant Protection : Fights free radicals and oxidative stress, slowing the aging process
Moreau X, Azorin J-M, Maurel M, Jeanningros R
